INTERNATIONAL PATENT: TYK MEDICINES, INC., 浙江同源康医药股份有限公司 FILES APPLICATION FOR "EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR FOR TREATING EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER WITH BRAIN METASTASIS"

Posted On: 2025-11-23

GENEVA, Nov. 23 -- TYK MEDICINES, INC. (Room 1403-2, Block A, Changxing World Trade Building, No. 1278 Mingzhu Road, Changxing Economic Development Zone,Huzhou, Zhejiang 313100), 浙江同源康医药股份有限公司 (中国浙江省湖州市长兴经济开发区明珠路1278号长兴世贸大厦A座14层1403-2室) filed a patent application (PCT/CN2025/093735) for "EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR FOR TREATING EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER WITH BRAIN METASTASIS" on May 09, 2025. With publica...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: TYK MEDICINES, INC., 浙江同源康医药股份有限公司 FILES APPLICATION FOR "EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR FOR TREATING EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER WITH BRAIN METASTASIS"